According to a recent market study published by Growth Market Reports, titled, “Global Cryopreservation Media Market By Type, By End-user and By Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 1,531.7 Million in 2022 and is anticipated to expand at a growth rate of 12.5% by 2031.
Get Sample Report @ https://growthmarketreports.com/request-sample/2580
Cryopreservation media generally comprised of a base medium, cryopreservative, and a protein source. The cryopreservative and protein protect the cells from the stress of the freeze-thaw process. Mammalian cells are cryopreserved to avoid loss by contamination, to minimize genetic change in continuous cell lines, and to avoid aging & transformation in finite cell lines. Cells are required to be characterized and checked for contamination before cryopreservation. Several media are commonly used to freeze cells.
The global Cryopreservation Media market has been segmented in terms of Type, End-user, and region. In terms of Type, the global Cryopreservation Media market is split into Serum-free and With Serum. Based on end-user, the market is divided into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cell Banks, and Others. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The COVID-19 pandemic had a considerable impact on various markets, including the Cryopreservation Media market. The COVID-19 disease induces serious respiratory diseases. Sperm cryopreservation is crucial in the management of patients undergoing gonadotoxic treatments. Concerns have increased about SARS-CoV-2 and its potential for testicular involvement, as SARS-CoV-2-positive cryopreserved samples have unknown effects on fertilization and embryo safety.
Key Takeaways from the Study:
-
Players in the global Cryopreservation Media market include Thermo Fisher Scientific Inc, Lonza, STEMCELL Technologies, Merck KGaA, Danaher (Cytiva), BioLife Solutions Inc., Bio-Techne, Sartorius AG (Biological Industries), HiMedia Laboratories, NIPPON Genetics EUROPE, Capricorn Scientific, PromoCell GmbH. These players held a major share of the global Cryopreservation Media market in 2022.
-
Growing Use in Cell-based Drug Discovery is key factors that drive the Cryopreservation Media market.
-
Emerging Markets is expected to create opportunities in the coming years.
-
Based on Type, the market is segmented into serum-free and with serum. The with serum segment is expected to hold a significant share of the market during the forecast period, as it is widely used for a broad spectrum of mammalian cell cultures.
-
Based on the end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, cell banks, and others. The cell banks segment is anticipated to expand at a significant CAGR during the forecast period, as cell banks are used routinely in bioproduction to support cell line development for biologics.
-
Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe accounted for a significant share of the market in 2022, due to the increasing healthcare spending in the region.
-
In 2021, the UK ranked fourth highest in terms of healthcare spending as a share of GDP. Germany, which spent 12.8% of its GDP on healthcare, ranked first. Rising number of biomedical research laboratories is expected to contribute to the high demand for cryopreservation media in the region during the forecast period.
Report Scope:
Report Metric |
Details |
Market Value in 2022 |
US$ 1,531.7 Million |
Market Growth Rate (from 2022 to 2031) |
12.5% |
Historical Data |
2016 & 2021 |
Base Year |
2022 |
Forecast Period |
2023 – 2031 |
Units Considered |
Value (US$ Million) |
Market Segments |
By Type, By End-user, and By Region |
Key Companies Profiled |
Thermo Fisher Scientific Inc, Lonza, STEMCELL Technologies, Merck KGaA, Danaher (Cytiva), BioLife Solutions Inc., Bio-Techne, Sartorius AG (Biological Industries), HiMedia Laboratories, NIPPON Genetics EUROPE, Capricorn Scientific, PromoCell GmbH. |
Customization Scope |
Report customization available on request |
Pricing and Purchase Options |
Avail of tailor-made purchase options to meet your research requirements. |
Target Audience:
-
Supply-side: Vendor, Manufacturer, Distributors, Supplier, Retailer.
-
Regulatory Side: Concerned government authorities, and other approved regulatory bodies.
-
Food and Drug Administration (FDA)
-
The Organization for Economic Cooperation and Development (OECD)